These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 25538167

  • 1. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
    Al-Hatmi AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF.
    J Antimicrob Chemother; 2015 Apr; 70(4):1068-71. PubMed ID: 25538167
    [Abstract] [Full Text] [Related]

  • 2. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.
    Tupaki-Sreepurna A, Thanneru V, Natarajan S, Sharma S, Gopi A, Sundaram M, Kindo AJ.
    Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920
    [Abstract] [Full Text] [Related]

  • 3. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
    Gupta C, Jongman M, Das S, Snehaa K, Bhattacharya SN, Seyedmousavi S, van Diepeningen AD.
    Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
    [Abstract] [Full Text] [Related]

  • 4. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.
    Homa M, Shobana CS, Singh YR, Manikandan P, Selvam KP, Kredics L, Narendran V, Vágvölgyi C, Galgóczy L.
    Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826
    [Abstract] [Full Text] [Related]

  • 5. In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
    Taj-Aldeen SJ, Salah H, Al-Hatmi AM, Hamed M, Theelen B, van Diepeningen AD, Boekhout T, Lass-Flörl C.
    Diagn Microbiol Infect Dis; 2016 Aug; 85(4):438-43. PubMed ID: 27312690
    [Abstract] [Full Text] [Related]

  • 6. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
    Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL.
    J Antimicrob Chemother; 2008 Apr; 61(4):805-9. PubMed ID: 18263569
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L, Wang Z, Li R, Luo S, Sun X.
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [Abstract] [Full Text] [Related]

  • 13. Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Genus Fusarium Causing Human Keratomycosis in South India.
    Hassan AS, Al-Hatmi AM, Shobana CS, van Diepeningen AD, Kredics L, Vágvölgyi C, Homa M, Meis JF, de Hoog GS, Narendran V, Manikandan P, IHFK Working Group.
    Med Mycol; 2016 Mar; 54(3):287-94. PubMed ID: 26705832
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC.
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
    Badali H, Cañete-Gibas C, Patterson H, Sanders C, Mermella B, Garcia V, Mele J, Fan H, Wiederhold NP.
    Mycoses; 2021 Jul; 64(7):748-752. PubMed ID: 33755988
    [Abstract] [Full Text] [Related]

  • 16. Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
    Debourgogne A, de Hoog S, Lozniewski A, Machouart M.
    Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):615-8. PubMed ID: 21744037
    [No Abstract] [Full Text] [Related]

  • 17. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
    Spader TB, Venturini TP, Rossato L, Denardi LB, Cavalheiro PB, Botton SA, Santurio JM, Alves SH.
    Rev Iberoam Micol; 2013 Apr; 30(3):200-4. PubMed ID: 23402831
    [Abstract] [Full Text] [Related]

  • 18. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.
    Espinel-Ingroff A, Colombo AL, Cordoba S, Dufresne PJ, Fuller J, Ghannoum M, Gonzalez GM, Guarro J, Kidd SE, Meis JF, Melhem TM, Pelaez T, Pfaller MA, Szeszs MW, Takahaschi JP, Tortorano AM, Wiederhold NP, Turnidge J.
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334
    [Abstract] [Full Text] [Related]

  • 19. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases].
    Çuhadar T, Karabıçak N, Özdil T, Özgür D, Otağ F, Hızel K, Kalkancı A.
    Mikrobiyol Bul; 2018 Jul; 52(3):247-258. PubMed ID: 30156511
    [Abstract] [Full Text] [Related]

  • 20. Luliconazole, a highly effective imidazole, against Fusarium species complexes.
    Gharaghani M, Hivary S, Taghipour S, Zarei-Mahmoudabadi A.
    Med Microbiol Immunol; 2020 Oct; 209(5):603-612. PubMed ID: 32253502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.